AU2219697A - Compositions and methods for inhibiting clot formation - Google Patents

Compositions and methods for inhibiting clot formation

Info

Publication number
AU2219697A
AU2219697A AU22196/97A AU2219697A AU2219697A AU 2219697 A AU2219697 A AU 2219697A AU 22196/97 A AU22196/97 A AU 22196/97A AU 2219697 A AU2219697 A AU 2219697A AU 2219697 A AU2219697 A AU 2219697A
Authority
AU
Australia
Prior art keywords
compositions
methods
clot formation
inhibiting clot
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22196/97A
Inventor
Robert J. Gould
George D. Hartman
Steven A. Nichtberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607513.0A external-priority patent/GB9607513D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2219697A publication Critical patent/AU2219697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU22196/97A 1996-03-27 1997-03-24 Compositions and methods for inhibiting clot formation Abandoned AU2219697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1421696P 1996-03-27 1996-03-27
US60014216 1996-03-27
GBGB9607513.0A GB9607513D0 (en) 1996-04-11 1996-04-11 Compositions and methods for inhibiting clot formation
GB9607513 1996-04-11
PCT/US1997/004739 WO1997035615A1 (en) 1996-03-27 1997-03-24 Compositions and methods for inhibiting clot formation

Publications (1)

Publication Number Publication Date
AU2219697A true AU2219697A (en) 1997-10-17

Family

ID=26309101

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22196/97A Abandoned AU2219697A (en) 1996-03-27 1997-03-24 Compositions and methods for inhibiting clot formation

Country Status (2)

Country Link
AU (1) AU2219697A (en)
WO (1) WO1997035615A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
GB2328873A (en) * 1997-09-08 1999-03-10 Merck & Co Inc The use of [3(R)-[2-(piperidin-4-yl)ethyl]-2-piperidone-1]acetyl-3(R)-methyl-ß-alanine for inhibiting blood platelet aggregation
GB2332373A (en) * 1997-12-19 1999-06-23 Merck & Co Inc Treatment of coronary and/or peripheral ischemia using an antithrombotic agent and an angiogenesis promoter
AR022909A1 (en) * 1999-03-11 2002-09-04 Du Pont Pharm Co SYNERGY BETWEEN LOW MOLECULAR HEPARINE AND INHIBITORS OF THE PLAQUETARY AGGREGATION, PROVIDING A COMBINED THERAPY FOR THE PREVENTION AND TREATMENT OF VARIOUS THROMBOEMBOLIC AFFECTIONS
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
US6849639B2 (en) 1999-12-14 2005-02-01 Amgen Inc. Integrin inhibitors and their methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502643A (en) * 1990-11-01 1994-03-24 スミスクライン・ビーチャム・コーポレイション γ-turn peptidomimetic compounds as fibrinogen antagonists
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives

Also Published As

Publication number Publication date
WO1997035615A1 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
AU1831597A (en) Methods and compositions for inhibiting hexokinase
AU6111699A (en) Novel method and compounds
AU2341097A (en) Music composition
AU4398897A (en) Mineral composition
AU1296099A (en) Methods and compositions for treating dermatoses
AU5898599A (en) Methods and compositions for genomic modification
AU9214398A (en) Compositions and methods for treating water
AU4261697A (en) Compounds and methods
AU6489396A (en) Methods of making viscoelastic compositions
AU1532297A (en) Starch-emulsifier composition and methods of making
AU2349399A (en) R-lansoprazole compositions and methods
AU3941797A (en) Novel thrombin inhibitors
AU6856496A (en) Compositions and methods for inhibiting corrosion
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU5157898A (en) Hnf3delta compositions
AU4577999A (en) Methods and compositions for inhibiting corrosion
AU7685798A (en) Compositions and methods for preventing adhesion
AU3352397A (en) Additive composition
AU4381097A (en) Bituminous composition
AU3396697A (en) Thrombin inhibitor
AU3200197A (en) New composition and methods
AU2219697A (en) Compositions and methods for inhibiting clot formation
AU3042697A (en) Thrombin inhibitors
AU4440199A (en) Methods and compositions for inhibition of angiogenesis